This GBD 2021 systematic analysis quantifies the global prevalence and disability burden of knee, hip, hand, and other osteoarthritis across 204 countries from 1990 to 2020. It uses population-based survey data and US insurance claims to produce site-specific estimates and projects case counts by joint through 2050. It also quantifies the contribution of high BMI as the sole formally modelled modifiable risk factor.
Hip and knee arthroplasty volumes are already straining health systems. With hip OA cases projected to increase 78.6% and knee OA cases 74.9% by 2050, the surgical backlog is not a future problem — it is already accumulating.
When counseling a patient with obesity and early knee or hip pain, quantify the stakes: high BMI is the only formally measured modifiable risk factor, responsible for roughly one-fifth of all osteoarthritis disability worldwide. Weight reduction before end-stage disease is not lifestyle advice. It is primary prevention with a measurable population impact.
The Kellgren-Lawrence grading system remains the reference standard for epidemiologic diagnosis: Grade 2: single defined osteophyte Grade 3: multiple osteophytes plus joint-space narrowing Grade 4: grade 3 criteria plus bone deformity
The authors explicitly state that joint replacement is highly effective for late-stage hip and knee osteoarthritis, but warn that access inequity will worsen as case numbers rise. Planning for equitable arthroplasty capacity, especially in lower-income regions, is a direct implication of this data.
This GBD 2021 systematic analysis quantifies the global prevalence and disability burden of knee, hip, hand, and other osteoarthritis across 204 countries from 1990 to 2020. It uses population-based survey data and US insurance claims to produce site-specific estimates and projects case counts by joint through 2050. It also quantifies the contribution of high BMI as the sole formally modelled modifiable risk factor.
Hip and knee arthroplasty volumes are already straining health systems. With hip OA cases projected to increase 78.6% and knee OA cases 74.9% by 2050, the surgical backlog is not a future problem — it is already accumulating.
When counseling a patient with obesity and early knee or hip pain, quantify the stakes: high BMI is the only formally measured modifiable risk factor, responsible for roughly one-fifth of all osteoarthritis disability worldwide. Weight reduction before end-stage disease is not lifestyle advice. It is primary prevention with a measurable population impact.
The Kellgren-Lawrence grading system remains the reference standard for epidemiologic diagnosis: Grade 2: single defined osteophyte Grade 3: multiple osteophytes plus joint-space narrowing Grade 4: grade 3 criteria plus bone deformity
The authors explicitly state that joint replacement is highly effective for late-stage hip and knee osteoarthritis, but warn that access inequity will worsen as case numbers rise. Planning for equitable arthroplasty capacity, especially in lower-income regions, is a direct implication of this data.